Asia Ambassador Program
15 AUGUST 2026 | 10:00-13:00 GMT +8 Beijing | Virtual
The Society for Clinical Research Sites (SCRS) invites you to the virtual Asia Ambassador Symposium!
Join clinical research sites and industry professionals for virtual learning and collaboration as we address clinical research challenges and opportunities within Asia. Come away with actionable strategies for successful site operations including study coordination, partnership management, patient enrollment, and more.
SCRS Ambassador Symposiums unify key members of a regional site community for greater site sustainability.
This 3-hour livestream symposium will share how clinical research sites across East Asia are approaching clinical trial execution.
Symposium Agenda
15 AUGUST 2026 | 10:00-13:00 GMT +8 Beijing | Virtual
9:00 – 9:15 |
Opening and Welcome |
9:15 – 9:45 |
The SCRS Site LandscapeGain insight into trends and metrics to position sites for success. Current survey data on enrollment and decentralized trials will be discussed by a panel of industry leaders. Use the information shared during this solution-focused discussion to make an impactful change at your organization. Li-Yuan Bai, M.D., M.M.S., Ph.D. Division of Hematology and Oncology at China Medical University Hospital, Director of the Department of Internal Medicine and the Division of Hematology and Oncology, Deputy Director of the Clinical Trial Center Michael Pierre, Project Manager, SCRS |
9:45 -9:30 |
Building a Unified Ecosystem: The Founding Mission and Next Steps for TACTCThis session highlights the mission of Taiwan Alliance of Clinical Trial Centers (TACTC) to unify Taiwan’s clinical trial sites into a coordinated ecosystem. By standardizing processes and sharing resources, it aims to accelerate study start-up, improve enrollment efficiency, and enhance global competitiveness. Next steps focus on pilot implementation and regional collaboration to advance site excellence across Asia. Chun-Jen Huang, Dean, Office of Human Research, Taipei Medical University Tina Sun, Chairman of Taiwan Clinical Research Association |
10:30 -10:40 |
Break |
10:40 -11:20 |
Regulatory Evolution & Regional HarmonizationThis session discusses the evolving landscape of Good Clinical Practice under ICH E6 (R3) and its implementation across Asia. It highlights key updates, including risk-based quality management, data governance, and decentralized trial considerations. The session focuses on regulatory alignment, practical challenges, and strategies for sponsors and sites to ensure compliance while advancing efficiency, consistency, and regional harmonization in clinical trials. Lillian Chiu, Director of Medical Development, Daiichisankyo Taiwan Arun Sundriyal, Ph.D, Executive Director, Clinical Operations, PPD, part of Thermo Fisher Scientific |
11:20 -12:20 |
Tech Innovation & Data EmpowermentThis session explores how AI and advanced analytics are transforming clinical trial operations, with a focus on drug development. By enabling real-time data capture and automated quality checks, these technologies enhance data accuracy, reduce manual workload, and streamline workflows. It highlights how digital innovation accelerates development, improves efficiency, and supports more adaptive, data-driven trials. YaFang Wu, Vice President, Data Management (global), Parexel International Tim Chen, Director, Customer Strategy, Medidata Solutions Aritra Bhowmik, APAC Site Success Manager, Cognizant |
12:20 -12:30 |
Closing |
*Qualified site attendees will receive a one-year digital SCRS membership scholarship for your location. To qualify, you must be currently working at a site located within the named SCRS Ambassador region. (Sites located or headquartered in any other geography are not eligible). SCRS membership benefits will be available to all registered staff at your physical location. SCRS membership benefits are not transferable from originating SCRS Ambassador scholarship award.
Ambassador Program Asia Regional Lead
Li-Yuan Bai, M.D., M.M.S., Ph.D.
Prof. Bai graduated from the National Yang-Ming University School of Medicine in 1987 and completed the PhD program at China Medical University in 2011.
Since 2005, Dr. Bai has been a visiting staff member in the Division of Hematology and Oncology at China Medical University Hospital in Taiwan. He currently serves as the Director of the Department of Internal Medicine and the Clinical Trial Center.
Dr. Bai’s areas of expertise include cancers of the gastrointestinal tract, pancreas, and biliary system, along with gastrointestinal stromal tumors and neuroendocrine tumors. He has participated in numerous global clinical trials in these fields and is the leading principal investigator in three investigator-initiated clinical trials. Additionally, he is actively involved in first-in-human and early-phase clinical trials, having engaged in 44 first-in-human or Phase I trials from 2014 to 2026.
Till now, Prof. Bai has published more than 160 peer-reviewed articles, including The Lancet, The New England Journal of Medicine, Nature Medicine, The Lancet Oncology, J Clin Oncology, Annals of Oncology, Research Communication, Cancer Research, Clinical Cancer Research, Hepatology, Biochemical Pharmacology, Gastric Cancer, and Cancer Cell Int, et al.